Introduction {#S0001}
============

Ultrasound assessment allows the facial skeleton and the neck of a fetus to be evaluated from the first trimester of pregnancy. However, the difficulties experienced in evaluating two-dimensional images and three-dimensional reconstructions result in fetal cervicofacial pathologies rarely being detected.

As these are rare anomalies, only a limited number of cases are typically reported by a single institution. Therefore, the newest information is of high value. The appearance of the fetal face changes in the course of pregnancy, and is associated with the deposition of fatty tissue, particularly in the region of the maxilla and cheeks. As the evaluation of the fetal face and the neck may present problems in the third trimester, due to the position of the fetus or location of the placenta on the anterior wall of the uterus being unfavorable, ultrasound assessment is usually most effective when performed prior to the 23^rd^--24^th^ week of gestation. Two-dimensional ultrasonography performed by an experienced diagnostician is considered to be a very accurate tool in the assessment of prenatal fetal cervicofacial malformations \[[@CIT0001]\].

3D ultrasonography is of great value in visualizing the surfaces of the head and neck and presenting the results to parents or other physicians involved in the care of neonates and infants \[[@CIT0002]\]. Sharing this information is especially important as cervicofacial tumors may compromise the upper airways, thus affecting the planning of *in utero* and perinatal treatment. Other methods such as magnetic resonance imaging (MRI) and fetoscopy may also be helpful in diagnosing pathologies resulting in upper airway patency in the fetus \[[@CIT0003], [@CIT0004]\].

Sonographic assessment allows a precise diagnosis to be established based on tumor category, location and vascularization pattern. However, the approach is much more difficult than a newborn evaluation or pathological study of a fetus, and differential diagnosis should be taken into consideration \[[@CIT0005]\].

Fetal cervicofacial tumors in prenatal ultrasound assessment {#S0002}
============================================================

Cystic hygromas are fetal tumors occurring within the neck region \[[@CIT0006]\] which can be described as bilateral hypoechogenic cyst-like cavities under ultrasound examination. They are best visualized in the coronal plane and may be detected as early as at the end of the first trimester of pregnancy \[[@CIT0007]\]. The presence of septations within the tumor may indicate the coexistence of aneuploidy \[[@CIT0008]\]. In cystic hygromas, a tendency towards regression can be observed in up to 10% of cases ([Figure 1](#F0001){ref-type="fig"}).

![Cystic hygroma of the neck in the fetus at 22 weeks' gestation. **A** -- 3D ultrasound scan of the fetal head and neck. **B** -- 2D ultrasound of the fetal head and neck, frontal plane](AMS-12-27889-g001){#F0001}

Other tumors detected by ultrasound examination of the fetal head and neck include lymphatic-venous malformations, lymphangiomas and hemangiomas. Although lymphatic-venous malformations are rare, they do not tend to demonstrate spontaneous involution during the first year of a child\'s life. Prenatal ultrasound identifies them as cystic tumors with multiple thin septations. Glossal lymphangiomas are also rarely found: ultrasound examination reveals solid or hyperechogenic tumors growing within the oral cavity. These anomalies seldom extend beyond their initial locations.

Large hemangiomas are detected by prenatal ultrasound examination in the region of the face, occiput and neck. They are characterized by rich, occasionally heavily calcified, vascularization \[[@CIT0009]\]. These tumors may be a component of Kasabach-Merritt syndrome. Severe thrombocytopenia, a life-threatening condition to a fetus or a neonate, accompanies the occurrence of these hemangiomas \[[@CIT0010]\].

Among other pathologies, richly vascularized tumors such as vascular lesions can significantly impair the cardiovascular system of the fetus, causing congestive heart failure \[[@CIT0011], [@CIT0012]\]. Unfortunately, no data exist concerning the problem in cases of cervicofacial tumors.

Epulis (Neumann\'s tumor), gingival pyogenic granuloma, is a benign abnormality most frequently originating from the maxillary gingiva. It is characterized by slow growth and is typically recognized as late as in the third trimester of pregnancy. Prenatal ultrasonography reveals it to be a solid tumor with poor vascularization ([Figure 2](#F0002){ref-type="fig"}).

![Epulis in the fetus at 36 weeks' gestation. **A** -- 3D ultrasound scan of the fetal head. **B** -- 2D ultrasound scan of the fetal head, sagittal plane](AMS-12-27889-g002){#F0002}

Epignathus is a very rare teratoma which develops within the oral cavity and the throat. It occasionally projects into the nasal cavity and the anterior cranial fossa. Histopathologically, it is most frequently a non-malignant tumor. However, there are some reports on partially malignant texture \[[@CIT0013]\]. Epignathus frequently arises from the sphenoid bone, hard or soft palate, pharynx, tongue or mandible. Ultrasound assessment allows a solid tumor of the oral cavity with elements of cysts and calcifications to be identified. In such cases, a detailed evaluation of the brain is necessary because the tumor can grow intracranially, resulting in hydrocephalus. Another oral cavity neoplasm occurring in the fetus is myoblastoma (Abrikosov\'s tumor), a rare non-malignant anomaly developing only in the oral cavity of female fetuses. On ultrasound examination, it presents as a solid tumor attached to the oral cavity floor.

Prenatal ultrasound scanning is also a reliable method of detecting superficial cervicofacial teratomas and thyroid tumors. Teratomas are typically solid hyperechogenic masses with the likely occurrence of cystic hypoechogenic spaces and calcification foci.

On prenatal ultrasound examination, thyroid tumors are well-isolated hyperechogenic tumors connected with the gland. Prenatal ultrasound color Doppler examination may reveal increased vascularity; however, discriminating between fetal hypothyroidism and hyperthyroidism based only on ultrasound may be difficult. Fetal tachycardia is known to be a good indicator of hyperthyroidism. Delayed bone maturation is a specific feature in fetuses with hypothyroid goiters \[[@CIT0014]\]. The occurrence of goiter in the fetus in subsequent gestations has also been documented \[[@CIT0015]\] ([Figure 3](#F0003){ref-type="fig"}).

![Goiter in the fetus at 22 weeks' gestation. **A** -- 3D ultrasound scan of the fetal head and neck. **B** -- 2D ultrasound scan of the fetal head and neck, sagittal plane](AMS-12-27889-g003){#F0003}

Other hyperechogenic tumors within the fetal head and neck, such as rhabdomyoma and rhabdomyosarcoma, have also occasionally been described \[[@CIT0016]\] ([Tables I](#T0001){ref-type="table"} and [II](#T0002){ref-type="table"}).

###### 

The list of articles identified in Medline concerning fetal cervicofacial tumors detected in prenatal ultrasound examination (years 2003--2012)

  Author\'s name   Publication year   Gestational age \[weeks\]   Tumor type                    Treatment and the fetus history
  ---------------- ------------------ --------------------------- ----------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Kornacki         2012               29                          Fetal goiter                  Cesarean section at the 29^th^ week of gestation. Newborn died after birth. For the next pregnancy, ultrasound prenatal examination, performed at week 19, revealed fetal goiter. Intra-amniotic levothyroxine pharmacotherapy. Cesarean section at the 37^th^ week of gestation. Child euthyroid. Normal growth and development
  Ince             2012               33                          Malignant epignathus          Cesarean section at the 33^rd^ week of gestation. Emergency tracheostomy. Partial excision of the tumor on the second day. Second operation with total excision of the tumor on 50^th^ day of life. Discharged from hospital with tracheostomy and gastrostomy
  Forys            2010               37                          Epulis                        Cesarean section at the 37^th^ week of gestation. EXIT procedure and tumor excision. Normal growth and development
  Clay             2009               32                          Cervical hemangioma           Cesarean section at the 35^th^ week of gestation. Postnatal pharmacotherapy. Scar observed, otherwise normal growth and development
  Johnson          2009               25                          Cervical teratoma             Cesarean section at the 37^th^ week of gestation. EXIT procedure. Newborn died after birth
  Mikovic          2009               21 and 23                   Two cases of cystic hygroma   Intrauterine OK-432 in tumor injection. Delivery at the 39^th^ week of gestation (delivered vaginally) and the 40^th^ week of gestation (Cesarean section). Normal growth and development in both children
  Dar              2009               12                          Epignathus                    Pregnancy termination at the 13^th^ week of gestation
  Antinolo         2009               21                          Epignathus                    Twin pregnancy. Other fetus normal. Cesarean section at the 33^rd^ week of gestation. EXIT procedure and tumor excision with reconstruction. No follow-up data
  Lassen           2008               31                          Fetal goiter                  Intra-amniotic levothyroxine pharmacotherapy. Cesarean section at the 40^th^ week of gestation. Normal growth and development
  Araujo Jr        2007               15                          Cervicofacial teratoma        Cesarean section at the 32^nd^ week of gestation. Orotracheal intubation and observation
  Phupong          2007               13                          Cystic hygroma                Spontaneous resolution. Delivery at the 40^th^ week of gestation. 47XYY karyotype, otherwise normal growth and development
  Valdez           2006               24                          Cervicofacial rhabdomyoma     Cesarean section at the 38^th^ week of gestation. Intubation and postnatal tumor excision. Recurrence of the lesion 14 months after the first surgery and repeated excision of the lesion. Four-year follow-up without recurrence. Normal growth and development
  Yoshida          2006               35.5                        Cervical hemangioma           Cesarean section at the 35^th^ week of gestation. EXIT procedure. Postnatal laser therapy, pharmacotherapy. Scar observed, otherwise normal growth and development
  Paladini         2005               21                          Cystic hygroma                Termination at the 22^nd^ week of gestation
  Sasaki           2003               25                          Cystic hygroma                Intrauterine OK-432 injection in tumor. Delivery at the 38^th^ week of gestation. Normal growth and development

###### 

Fetal cervicofacial tumors. Differential diagnoses by ultrasound and color Doppler

  Cervicofacial tumors    Ultrasound characteristics
  ----------------------- -----------------------------------------------------------------------------------------------------------------------------------------
  Cystic hygroma          Solid tumor. Frequent location within the tongue and the cervical region. The presence of septations may suggest chromosomal defects
  Teratoma                Solid tumor, occasionally with cystic elements and calcifications in different areas, frequently within the oral cavity and the pharynx
  Epulis                  Solid tumor with poor vascularization localized within the oral vestibule
  Vascular malformation   Cystic tumor with multiple thin septations. Color Doppler would show vascularization
  Hemangioma              Well-isolated tumor, increased blood flow in Doppler examination
  Myoblastoma             Solid tumor. Frequent localization within the oral cavity
  Thyroid tumor           Cervical solid tumor. Well isolated, connected with the thyroid gland, may present with increased vascularization

*In utero* treatment, gestation planning and postnatal treatment in cases of prenatally diagnosed fetal cervicofacial tumors {#S0003}
============================================================================================================================

Initial reports suggest the possibility of *in utero* removal of fetal cervicofacial tumors. Removal of tumors *in utero* has already been employed in the treatment of fetal malformations in other localizations, such as teratomas in the sacrococcygeal region \[[@CIT0017], [@CIT0018]\]. The first successful intrauterine removal of a fetal cervicofacial tumor was performed by Kontopoulos *et al*., University of Miami/Jackson Memorial Hospital, in 2012 \[[@CIT0003]\].

When the tumor mass is large, impaired swallowing of amniotic fluid may additionally occur, resulting in polyhydramnios at the beginning of the third trimester of pregnancy. Amniodrainage is used to relieve maternal discomfort in cases of polyhydramnios and to prevent the complications associated with increased intrauterine pressure, such us preterm labor, premature rupture of membranes (PROM) and fetal hypoxia \[[@CIT0019]\].

Fetal goiters may accompany mother hypothyroidism and are occasionally induced by propylthiouracil treatment during pregnancy. Some studies report good outcomes of fetal goiter treatment after intra-amniotic injections of levothyroxine \[[@CIT0020]\].

In cases that carry a poor prognosis for the affected fetus due to the presence of the tumor or confirmed chromosomal defects before the 24^th^ week of gestation, termination of pregnancy can be considered, especially when other defects concomitant with cervicofacial tumors of the fetus are diagnosed \[[@CIT0021]\].

A considerable proportion of cervicofacial tumors demonstrate a tendency for postnatal idiopathic regression. Therefore, in cases which do not indicate any need for urgent surgery due to malignancy, large deformations caused by the tumor (torticollis, sternocleidomastoid muscle hypoplasia) or impairment of swallowing and breathing, the treatment of choice is to observe the tumors. If no regression is observed, a surgical procedure, postnatal surgery involving tumor resection combined with simultaneous reconstructive procedures, is considered in the first year of life of the child \[[@CIT0022]\]. Treatment of cystic hygromas and vascular malformations involves tumor resection or sclerotherapy with picibanil preparation (OK-432 -- also *in utero* therapy) and local steroid therapy \[[@CIT0023]\].

Surgical removal of hemangiomas is currently only rarely performed. The implementation of non-selective β-blockers such as propranolol and acebutolol has changed the management in the case of juvenile hemangiomas and improved postnatal prognosis. The treatment usually lasts until the end of the first year of life, i.e. until the time of tumor involution \[[@CIT0024]\].

Perinatal airway management in neonates and outcomes in cases of prenatally diagnosed fetal cervicofacial tumors {#S0004}
================================================================================================================

At the last stage of pregnancy, the size of the pathological structure is of great significance. Fetal morphological defects such as tumors exceeding 50 mm are regarded as an indication for delivery by cesarean section \[[@CIT0025]\]. Tumors that obstruct the respiratory tract at the level of the upper, middle or lower pharynx, larynx or trachea, either completely or to a great extent, can lead to congenital high-airway obstruction syndrome (CHAOS). In such situations, two possibilities are taken into consideration during perinatal management, with delivery by cesarean section being recommended for neonates.

In the case of airway obstruction, the EXIT procedure, ex-utero intrapartum treatment, is considered. Following the cesarean section, intraoperative ultrasound is performed at the suprapubic region to determine the attachment of the placenta. The attachment of the placenta can be determined clearly before the operation. A hysterotomy is then carried out to reveal the fetal head. The newborn is intubated and its condition is monitored. Next, the umbilical cord is clamped. If intubation is unsuccessful, urgent tracheotomy and possible tumor surgery are considered \[[@CIT0026]--[@CIT0028]\].

Although *in utero* therapy and perinatal treatment may considerably improve the chance of survival of fetuses with cervicofacial pathologies, the typical survival rate is poor. Such prenatal risks as hydramnios, preterm birth possibility, PROM, abnormal karyotype, and combined and complex abnormalities worsen the prognosis \[[@CIT0029]\]. According to Kamil *et al*., considerably higher mortality rates are observed for head and neck fetal tumors and sacrococcygeal tumors than tumors of other locations, the respective rates being 52.6% and 33.3%. Mortality rates are also considerably higher in cases of teratoma. The presence of hydrops fetalis independently predicted an unfavorable outcome in most cases of fetal tumors \[[@CIT0005]\].

Prenatal ultrasound examination provides the necessary information regarding the pathology of the head and neck, including tumors. The presence of a neoplasm as well as its topography in relation to other structures, including the airway, and large cervical vessels can be identified, which allows perinatal care and subsequent procedures to be planned. Cervicofacial tumors identified during fetal life represent not only a diagnostic but also a therapeutic challenge for pediatric specialists. Knowledge of the presence of a tumor obstructing or compressing the upper respiratory tract is extremely important for perinatal care and planning to secure the airway of the neonate. Therefore, greater cooperation should be encouraged between diagnosticians performing the ultrasound assessments of the fetal head and neck, and the pediatric laryngologists, surgeons and anesthetists responsible for the child in the perinatal, neonatal and infantile periods \[[@CIT0030]\].

Conflict of interest {#S0005}
====================

The authors declare no conflict of interest.
